Henry Schein, Inc. $HSIC Shares Sold by Northern Trust Corp

Key Points

• Northern Trust Corp has reduced its stake in Henry Schein, Inc. by 6.0%, now owning approximately 1.06% of the company, valued at around $88.6 million.
• Henry Schein reported $1.10 EPS for its last quarter, falling short of analyst expectations, although its revenue was slightly above forecasts at $3.24 billion.
• Wall Street analysts have varied opinions on Henry Schein, with target prices being revised down; the average stock rating is currently "Hold" with a consensus target price of $75.58.

Northern Trust Corp lowered its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 6.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,293,426 shares of the company's stock after selling 83,089 shares during the period. Northern Trust Corp owned 1.06% of Henry Schein worth $88,587,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the stock. Investment Management Corp VA ADV purchased a new stake in shares of Henry Schein during the 4th quarter valued at $32,000. Rakuten Securities Inc. purchased a new stake in shares of Henry Schein during the 1st quarter valued at $34,000. Whittier Trust Co. lifted its holdings in shares of Henry Schein by 714.3% during the 1st quarter. Whittier Trust Co. now owns 798 shares of the company's stock valued at $55,000 after purchasing an additional 700 shares during the last quarter. UMB Bank n.a. lifted its holdings in shares of Henry Schein by 23.2% during the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after purchasing an additional 201 shares during the last quarter. Finally, Allworth Financial LP lifted its holdings in shares of Henry Schein by 24.5% during the 1st quarter. Allworth Financial LP now owns 1,178 shares of the company's stock valued at $78,000 after purchasing an additional 232 shares during the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have recently commented on HSIC shares. JPMorgan Chase & Co. decreased their price objective on Henry Schein from $80.00 to $76.00 and set an "overweight" rating for the company in a report on Thursday, August 7th. UBS Group decreased their price objective on Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a report on Wednesday, August 6th. Wells Fargo & Company cut their target price on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 6th. Leerink Partners set a $75.00 target price on Henry Schein in a research report on Monday, July 14th. Finally, Baird R W downgraded Henry Schein from a "strong-buy" rating to a "hold" rating in a research report on Monday, July 14th. Five analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, Henry Schein presently has a consensus rating of "Hold" and a consensus target price of $76.67.

Henry Schein Stock Performance

HSIC traded up $0.55 during midday trading on Friday, hitting $69.58. 1,021,767 shares of the company were exchanged, compared to its average volume of 2,115,911. The company's 50 day simple moving average is $70.35 and its 200 day simple moving average is $70.04. The firm has a market capitalization of $8.44 billion, a price-to-earnings ratio of 22.45, a price-to-earnings-growth ratio of 2.30 and a beta of 0.81. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. Henry Schein, Inc. has a 1-year low of $60.56 and a 1-year high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.09). The company had revenue of $3.24 billion for the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.Henry Schein's revenue for the quarter was up 3.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.23 earnings per share. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. As a group, sell-side analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.